相关实验视频

Updated: Jul 5, 2025

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

针对肝脏的纳米平台用于诱导免疫耐受性

Sydney Kusumoputro^1,2, Christian Au^3,4, Katie H Lam^4,5

¹Department of Medicine, Drexel University College of Medicine, Philadelphia, PA 19129, USA.

Nanomaterials (Basel, Switzerland)

|January 11, 2024

概括

针对肝脏的纳米粒子提供了一种灵活的方法来诱导免疫耐受性,用于治疗免疫疾病. 本综述涵盖了针对肝细胞的纳米粒子设计和过敏和自身免疫性疾病的治疗应用.

科学领域:

免疫学免疫学免疫学
纳米技术纳米技术
肝病学肝病学是一种肝病学.

背景情况:

肝脏独特的耐受性特性被用来诱导免疫耐受性.
纳米粒子为治疗应用提供物理化学灵活性.
通过这种方法,可能可以治疗各种免疫性疾病.

研究的目的:

对免疫耐受性的肝脏向纳米粒子设计进行审查.
评估针对关键肝细胞 (LSEC,KC,HSC,肝细胞) 的策略.
探索过敏和自身免疫性疾病的治疗应用.

主要方法:

对细胞特异向纳米颗粒设计参数的审查.
对为肝细胞向设计的纳米平台的分析.
使用向肝脏的纳米粒子治疗策略的概述.

主要成果:

纳米粒子可以被设计为针对特定的肝细胞进行免疫调节.
针对过敏和自身免疫性疾病正在探索各种治疗策略.
这种方法对治疗一系列免疫学疾病充满希望.

结论:

针对肝脏的纳米颗粒是诱导免疫耐受性的通用平台.
需要进一步的研究来克服挑战并扩大治疗效用.
未来的途径侧重于提高纳米粒子在自身免疫过程中的应用.

关键词:

过敏过敏过敏自身免疫性疾病自身免疫性疾病免疫耐受性免疫耐受性针对肝脏的纳米颗粒.

更多相关视频

In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction

In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction

Published on: January 22, 2020

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

相关概念视频

Special Features of Adaptive Immunity

Special Features of Adaptive Immunity

The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...

Cell-mediated Immune Responses

Cell-mediated Immune Responses

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.